These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Naproxen-induced pseudoporphyria: appearance of new skin lesions after discontinuation of treatment. Girschick HJ; Hamm H; Ganser G; Huppertz HI Scand J Rheumatol; 1995; 24(2):108-11. PubMed ID: 7747141 [TBL] [Abstract][Full Text] [Related]
13. Successful outcome of haemodialysis-induced pseudoporphyria after short-term oral N-acetylcysteine and switch to high-flux technique dialysis. Massone C; Ambros-Rudolph CM; Di Stefani A; Müllegger RR Acta Derm Venereol; 2006; 86(6):538-40. PubMed ID: 17106603 [TBL] [Abstract][Full Text] [Related]
14. [Isotretinoin (Roaccutane) in women of childbearing age: failure of following prescription guidelines]. Autret E; Radal M; Jonville-Béra AP; Goehrs JM Ann Dermatol Venereol; 1997; 124(8):518-22. PubMed ID: 9740842 [TBL] [Abstract][Full Text] [Related]
15. Pseudoporphyria induced by propionic acid derivatives. Al-Khenaizan S; Schechter JF; Sasseville D J Cutan Med Surg; 1999 Jan; 3(3):162-6. PubMed ID: 10082597 [TBL] [Abstract][Full Text] [Related]
16. Studies of laminin and type IV collagen in blisters of porphyria cutanea tarda and drug-induced pseudoporphyria. Dabski C; Beutner EH J Am Acad Dermatol; 1991 Jul; 25(1 Pt 1):28-32. PubMed ID: 1880250 [TBL] [Abstract][Full Text] [Related]
17. Pseudoporphyria from nonsteroidal antiinflammatory drugs. Taylor BJ; Duffill MB N Z Med J; 1987 May; 100(824):322-3. PubMed ID: 3451093 [TBL] [Abstract][Full Text] [Related]